02nd May 2022 | Pharma Updates

PharmaState Updates – Latest Pharma Happenings

Pharmaceutical exports expected to reach Rs 1.83 lakh crore in 2021-22

Exports of pharmaceuticals reached Rs 1,83,422 crore in 2021-22, up from Rs 90,415 crore in 2013-14. Despite global trade interruptions and a reduction in demand for COVID-related drugs, exports in 2021-22 grew at a favourable rate.

Adani aims to invest $4 billion on healthcare

Gautam Adani is planning major investments in the healthcare sector, including the purchase of significant hospitals, diagnostic chains, and offline and online pharmacies, among other assets, in order to gain a foothold in the industry.

As unsold Covid medicines pile up, companies facing massive losses

Industry is dealing with a large inventory of raw ingredients and medications utilised in Covid-19, as well as the prospect of massive losses and write-offs in the hundreds of crores.

Chief of Pfizer's vaccines division to retire this year

Kathrin Jansen, the head of vaccines at Pfizer Inc., will retire later this year after leading the development of the company’s COVID-19 vaccine.

Gujarat exports approximately a quarter of all pharmaceuticals

Minister of Women and Child Development Smriti Irani praised the state’s role in the pharma sector on Sunday, saying that Gujarat accounts for approximately 25% of India’s $24 million in exports.

Higher input expenses challenge for Himachal pharma firms

The pharmaceutical business in Himachal, particularly micro, small, and medium enterprises, has been shaken by a sharp increase in raw material prices combined with growing logistics and packaging costs.

AstraZeneca believes its COVID injection has market potential despite decreasing demand

With a predicted global oversupply of shots and delays in the vaccine’s licencing in the United States, AstraZeneca’s COVID-19 vaccine still has market potential.

Covid-19 vaccine plant to be built in Canada by Moderna

Vaccine Covid-19’s developer Moderna plans to construct a manufacturing plant in Quebec, which will be capable of producing up to 100 million mRNA vaccine doses per year.